A detailed history of Busey Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Busey Wealth Management holds 2,856 shares of NVS stock, worth $296,481. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,856
Previous 3,717 23.16%
Holding current value
$296,481
Previous $395,000 16.96%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$106.13 - $120.89 $91,377 - $104,086
-861 Reduced 23.16%
2,856 $328,000
Q2 2024

Jul 23, 2024

SELL
$92.57 - $107.37 $39,064 - $45,310
-422 Reduced 10.2%
3,717 $395,000
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $20,292 - $23,104
213 Added 5.43%
4,139 $400,000
Q4 2023

Jan 25, 2024

BUY
$92.27 - $101.54 $29,526 - $32,492
320 Added 8.87%
3,926 $396,000
Q3 2023

Oct 23, 2023

SELL
$94.73 - $105.13 $66,974 - $74,326
-707 Reduced 16.39%
3,606 $367,000
Q2 2023

Jul 21, 2023

SELL
$92.52 - $104.91 $27,756 - $31,473
-300 Reduced 6.5%
4,313 $435,000
Q1 2023

Apr 25, 2023

SELL
$80.03 - $92.81 $1,440 - $1,670
-18 Reduced 0.39%
4,613 $424,000
Q4 2022

Jan 23, 2023

SELL
$75.55 - $92.52 $2,644 - $3,238
-35 Reduced 0.75%
4,631 $0
Q3 2022

Oct 24, 2022

SELL
$74.61 - $87.26 $9,550 - $11,169
-128 Reduced 2.67%
4,666 $355,000
Q2 2022

Aug 01, 2022

BUY
$80.52 - $93.75 $1,449 - $1,687
18 Added 0.38%
4,794 $405,000
Q1 2022

Apr 21, 2022

SELL
$80.11 - $90.62 $47,505 - $53,737
-593 Reduced 11.04%
4,776 $420,000
Q4 2021

Jan 25, 2022

SELL
$79.7 - $88.13 $20,243 - $22,385
-254 Reduced 4.52%
5,369 $470,000
Q3 2021

Oct 29, 2021

BUY
$81.78 - $95.14 $70,903 - $82,486
867 Added 18.23%
5,623 $460,000
Q2 2021

Jul 22, 2021

SELL
$85.24 - $94.15 $4,006 - $4,425
-47 Reduced 0.98%
4,756 $433,000
Q1 2021

Apr 20, 2021

SELL
$83.5 - $98.47 $31,730 - $37,418
-380 Reduced 7.33%
4,803 $411,000
Q4 2020

Jan 20, 2021

SELL
$78.07 - $94.43 $181,122 - $219,077
-2,320 Reduced 30.92%
5,183 $490,000
Q3 2020

Oct 16, 2020

SELL
$82.14 - $91.0 $5,831 - $6,461
-71 Reduced 0.94%
7,503 $653,000
Q2 2020

Jul 21, 2020

SELL
$80.93 - $91.1 $67,819 - $76,341
-838 Reduced 9.96%
7,574 $662,000
Q1 2020

Apr 17, 2020

SELL
$70.67 - $99.01 $1,484 - $2,079
-21 Reduced 0.25%
8,412 $694,000
Q4 2019

Feb 11, 2020

BUY
$84.35 - $95.37 $122,307 - $138,286
1,450 Added 20.76%
8,433 $798,000
Q3 2019

Nov 12, 2019

BUY
$85.54 - $94.26 $397,589 - $438,120
4,648 Added 199.06%
6,983 $607,000
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $980 - $1,206
-13 Reduced 0.55%
2,335 $214,000
Q1 2019

Apr 16, 2019

BUY
$75.32 - $86.15 $176,851 - $202,280
2,348 New
2,348 $225,000
Q1 2018

May 04, 2018

SELL
$70.39 - $84.15 $170,977 - $204,400
-2,429 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$72.33 - $77.64 $175,689 - $188,587
2,429
2,429 $204,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Busey Wealth Management Portfolio

Follow Busey Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.